Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Teladoc Health in a research note issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of ($0.40) per share for the quarter, down from their prior estimate of ($0.38). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health's Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($1.08) EPS, Q2 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.90) EPS.
TDOC has been the topic of several other research reports. Piper Sandler decreased their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Royal Bank of Canada lifted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. The Goldman Sachs Group cut their price objective on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Finally, Bank of America lifted their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research report on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $11.26.
Read Our Latest Stock Report on TDOC
Teladoc Health Price Performance
Shares of NYSE:TDOC traded down $0.29 during trading on Monday, hitting $8.21. 3,027,705 shares of the stock were exchanged, compared to its average volume of 6,010,063. The company has a fifty day moving average price of $10.48 and a two-hundred day moving average price of $9.73. The company has a market cap of $1.42 billion, a PE ratio of -1.42 and a beta of 1.27. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $15.68.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.
Institutional Trading of Teladoc Health
Several institutional investors have recently made changes to their positions in TDOC. Versant Capital Management Inc boosted its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC raised its stake in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its stake in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after acquiring an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $60,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
